- BNF:
- Not listed
- Status:
- Red
- Decision Date:
- October 2016
Comments
RED1,2,3 - NICE TA408 for treating acute lymphoblastic leukaemia. (Decision date - October 2016)
NHSE are the responsible commissioner for this drug.
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
search again